MBMelika Boroomand-Saboor

Melika Boroomand-Saboor

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Melika Boroomand-Saboor has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Methamphetamine-predominant clinical groups show altered residence in recurring whole-brain connectivity states

    by Farzad Ashrafi, Javad Sheikhi Koohsar, Melika Boroomand-Saboor, Shabnam Nohesara, Mehran Arab-Ahmadi

    Methamphetamine-predominant substance use has been linked to altered large-scale brain networks, but it remains unclear whether the temporal organization of whole-brain connectivity is characterized by increased switching or by altered residence in specific network states. We analyzed resting-state functional MRI from 110 adult male participants: active methamphetamine users, methadone-maintained individuals with methamphetamine-predominant histories, and healthy controls. Dynamic functional connectivity was estimated from 167 brain regions using Hamming-tapered sliding windows, and latent states were identified with a three-state hidden Markov model selected using unsupervised criteria and tested across window lengths, state-estimation methods, principal-component retention thresholds, and random initializations. Fractional occupancy was treated as a compositional outcome and adjusted for age, mean framewise displacement, and percentage of scrubbed volumes. The full occupancy composition differed robustly across groups. Both clinical groups occupied a clinical-enriched state more often and a control-enriched state less often than controls. Dwell-time analyses showed the same pattern, whereas transition count and transition rate did not differ. Clinical associations within the two patient groups did not survive false-discovery-rate correction. These findings indicate that methamphetamine-predominant clinical groups differ from controls primarily in the allocation of time across recurring brain-network states, not in globally increased switching.

  • Open Access

    Role of uterine artery Doppler sonography in prediction and management of preeclampsia: a systematic review analysis of the recent 10-year evidence

    by Sina Salem Ahim, Maryam Kazemi, Melika Boroomand-Saboor, Zeinab Zamanpour, Hamideh Rahbarinezhad, Tahereh Mahmoodvand, Sara Ghaseminejad Kermani, Sadaf Rassouli, Zahra Hamidi Madani

    Introduction: Preeclampsia (PE) is a leading cause of maternal and perinatal morbidity worldwide, and early identification of at-risk pregnancies remains a clinical priority. This systematic review synthesizes evidence from the past decade to evaluate the diagnostic performance and clinical utility of uterine artery Doppler (UAD) sonography in predicting and guiding management of PE. Materials and Methods: We systematically searched PubMed, Embase, Scopus, Web of Science, Cochrane Library, and Google Scholar for English-language original studies published between 2016 and 2025 that evaluated UAD parameters for predicting PE. Two reviewers independently extracted data on study design, gestational timing, Doppler findings, and diagnostic accuracy using a standardized form. Results: In this review of 18 observational and cohort studies published over the past decade, UAD sonography demonstrated moderate to high diagnostic accuracy for predicting PE, with parameters such as pulsatility index (PI), resistive index (RI), and the presence of a diastolic notch, alone or in combination, yielding sensitivities ranging from ~60% to 91% and specificities up to 99%. First-trimester assessments showed particular promise, especially when Doppler indices were combined with biochemical markers, and second-trimester measurements maintained predictive value for both early- and late-onset disease. Conclusion: These findings pose UAD sonography as a noninvasive, cost-effective tool for early risk stratification of PE and support its incorporation into routine antenatal screening. Registration: This study has been compiled based on the PRISMA checklist, and its protocol was registered on the PROSPERO (ID: CRD420251173030 and the Research Registry (UIN: reviewregistry2054) websites.